NCT00187096View on ClinicalTrials.gov

Natural Killer (NK) Cell Transplantation for AML

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2013

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2

See Detailed Description section for additional details of treatment interventions.

PROCEDURE

Natural Killer Cell Infusion

See Detailed Description section for additional details of treatment interventions.

DEVICE

CliniMACS System

See Detailed Description section for additional details of treatment interventions.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00187096 - Natural Killer (NK) Cell Transplantation for AML | Biotech Hunter | Biotech Hunter